Royce & Associates »

Supernus Pharmaceuticals shares owned by Royce & Associates

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Royce & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 41k 47.79
2025-06-30 $1.0M 33k 31.52
2025-03-31 $805k 25k 32.75
2024-12-31 $468k 13k 36.16
2023-09-30 $517k 19k 27.57
2023-03-31 $1.6M 44k 36.22
2022-12-31 $1.6M 44k 35.66
2022-09-30 $1.5M 45k 33.84
2022-06-30 $1.3M 45k 28.91
2022-03-31 $1.7M 54k 32.32
2021-12-31 $7.5M 258k 29.16
2021-09-30 $9.9M 371k 26.67
2021-06-30 $11M 367k 30.79
2021-03-31 $9.9M 376k 26.18
2020-12-31 $9.7M 387k 25.16
2020-09-30 $6.2M 298k 20.84
2020-06-30 $5.9M 247k 23.75
2020-03-31 $4.2M 233k 17.99
2019-12-31 $5.9M 250k 23.72
2019-09-30 $6.0M 217k 27.48
2019-06-30 $471k 14k 33.12
2019-03-31 $277k 7.9k 35.05
2018-06-30 $3.5M 58k 59.84
2018-03-31 $3.1M 67k 45.81
2017-12-31 $3.9M 99k 39.85
2017-09-30 $6.4M 159k 40.00
2017-06-30 $6.9M 159k 43.10
2017-03-31 $4.1M 130k 31.30